Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.

@article{Taylor2008ImpactOR,
  title={Impact of risperidone long acting injection on resource utilization in psychiatric secondary care.},
  author={Mark Taylor and Ann Currie and Keith Lloyd and Martin J. Price and Kate Peperell},
  journal={Journal of psychopharmacology},
  year={2008},
  volume={22 2},
  pages={128-31}
}
Risperidone long acting injection (RLAI) is the only long acting atypical antipsychotic available in the UK. Its impact on NHS resource use has not been widely studied. This review of medical records was conducted to quantify the impact of RLAI on NHS psychiatric secondary care resource use, primarily in terms of episodes of inpatient hospital care 12… CONTINUE READING